ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,003Medicare Part D Prescriptions Filled, Including Refills

Rank: 81 out of 617

$510K Total Retail Price of All Prescriptions

Rank: 93 out of 617

516 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 516 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 516 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 9,328 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
WARFARIN SODIUM 547 455 1 7
OMEPRAZOLE 521 422 2 3
LOSARTAN-HYDROCHLOROTHIAZIDE 465 420 3 46
SIMVASTATIN 443 375 4 2
AMLODIPINE BESYLATE 424 397 5 6
LOSARTAN POTASSIUM 396 375 6 22
CITALOPRAM HBR 323 246 7 18
FUROSEMIDE 312 265 8 4
METFORMIN HCL 265 215 9 9
LEVOTHYROXINE SODIUM 234 226 10 1
LISINOPRIL-HYDROCHLOROTHIAZIDE 211 175 11 29
CARVEDILOL 210 182 12 19
GABAPENTIN 179 166 13 16
METOPROLOL SUCCINATE 176 172 14 12
LISINOPRIL 175 154 15 5
TAMSULOSIN HCL 164 132 16 26
MELOXICAM 158 133 17 24
TRAMADOL HCL 157 97 18 15
HYDROCODONE-ACETAMINOPHEN 152 99 S3 19 8
POTASSIUM CHLORIDE 146 136 20 10
ZOLPIDEM TARTRATE 141 123 21 23
PREDNISONE 130 123 22 31
METOPROLOL TARTRATE 116 101 23 11
ALLOPURINOL 114 101 24 27
ADVAIR DISKUS 106 82 25 38
CRESTOR 103 92 26 28
ATENOLOL 101 72 27 17
PRAVASTATIN SODIUM 100 93 28 21
ACTOS 87 76 29 85
CYMBALTA 81 64 30 49
DIOVAN HCT 81 76 30 97
ATORVASTATIN CALCIUM 79 68 32 14
LYRICA 79 57 32 92
MUPIROCIN 76 51 34 176
POLYETHYLENE GLYCOL 3350 73 67 35 32
LANTUS 72 68 36 39
BYSTOLIC 67 52 37 64
DIGOXIN 66 66 38 48
AZITHROMYCIN 65 59 39 70
DONEPEZIL HCL 63 63 40 30
SERTRALINE HCL 61 48 41 20
SPIRIVA 60 43 42 61
ESCITALOPRAM OXALATE 60 59 42 65
CLONIDINE HCL 59 55 44 55
ALENDRONATE SODIUM 57 53 45 25
EVISTA 57 57 45 119
FENTANYL 56 56 S2 47 45
DIOVAN 53 46 48 41
TRIAMCINOLONE ACETONIDE 52 46 49 102
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 15, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.